1. Generating and weighing evidence in drug development and regulatory decision making: 5th US FDA–DIA workshop on pharmacogenomics. (December 2010) Authors: Shaw, Peter M; Zineh, Issam Journal: Pharmacogenomics Issue: Volume 11:Number 12(2010) Page Start: 1629 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Generating and weighing evidence in drug development and regulatory decision making: 5th US FDA–DIA workshop on pharmacogenomics. (December 2010) Authors: Shaw, Peter M; Zineh, Issam Journal: Pharmacogenomics Issue: Volume 11:Number 12(2010) Page Start: 1629 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Mobilizing pharmacogenomic analyses during clinical trials in drug development. (July 2013) Authors: Bienfait, Karina L; Shaw, Peter M; Murthy, Gowri; Warner, Amelia Wall Journal: Pharmacogenomics Issue: Volume 14:Number 10(2013) Page Start: 1227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pharmacogenomic data submissions to the FDA: clinical case studies. (1st July 2004) Authors: Trepicchio, William L; Williams, Grant A; Essayan, David; Hall, Sue T; Harty, Lea C; Shaw, Peter M; Spear, Brian B; Wang, Sue Jane; Watson, Mark L Journal: Pharmacogenomics Issue: Volume 5:Number 5(2004) Page Start: 519 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Prospective––retrospective biomarker analysis for regulatory consideration: white paper from the industry pharmacogenomics working group. (July 2011) Authors: Patterson, Scott D; Cohen, Nadine; Karnoub, Maha; Truter, Sharada Louis; Emison, Eileen; Khambata-Ford, Shirin; Spear, Brian; Ibia, Ekopimo; Sproule, Rizwana; Barnes, Diane; Bhathena, Anahita; Bristow, Michael R; Russell, Chris; Wang, Dai; Warner, Amelia; Westelinck, Agnes; Brian, William; Snapir... Journal: Pharmacogenomics Issue: Volume 12:Number 7(2011) Page Start: 939 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Prospective––retrospective biomarker analysis for regulatory consideration: white paper from the industry pharmacogenomics working group. (July 2011) Authors: Patterson, Scott D; Cohen, Nadine; Karnoub, Maha; Truter, Sharada Louis; Emison, Eileen; Khambata-Ford, Shirin; Spear, Brian; Ibia, Ekopimo; Sproule, Rizwana; Barnes, Diane; Bhathena, Anahita; Bristow, Michael R; Russell, Chris; Wang, Dai; Warner, Amelia; Westelinck, Agnes; Brian, William; Snapir... Journal: Pharmacogenomics Issue: Volume 12:Number 7(2011) Page Start: 939 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Voriconazole pharmacogenetics – Authors' reply. Issue 10300 (14th August 2021) Authors: Maertens, Johan A; Waskin, Hetty A; West, Rachel Marceau; Shaw, Peter M Journal: Lancet Issue: Volume 398:Issue 10300(2021) Page Start: 578 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗